Phase I Dose Escalation Study of VS-4718 in Subjects With Metastatic Non-Hematologic Malignancies
Clinical trial NCT01849744 · TERMINATED
Trial details
- NCT number
- NCT01849744
- Sponsor
- Verastem, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2017-04-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.